Skip to content Skip to footer
Inflectra: Benefits, Reviews, Info, Side Effects!
Rx Details
Inflectra
Remsima, Infliximab, CT-P13
Infliximab
Prescription
Biologic
Drugs
Biosimilar
biosimilar to Remicade, treats autoimmune diseases, reduces inflammation, manages symptoms of rheumatoid arthritis, helps with Crohn’s disease, treats ulcerative colitis, manages ankylosing spondylitis, helps with psoriatic arthritis, treats plaque psoriasis
Abdominal Pain, Back Pain, Cough, Dizziness, Fatigue, Fever, Headache, Infections, Infusion-Related Reactions, Itching, Nausea, Rash, Upper Respiratory Tract Infection
Inflectra is a biosimilar to Remicade (infliximab) and is used to treat various autoimmune conditions such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. The dosage of Inflectra can vary depending on the condition being treated, the patient’s weight, and their response to the medication. For most conditions, the typical starting dosage is 5 mg/kg, administered as an intravenous infusion. The initial dosing schedule often includes an infusion at week 0, week 2, and week 6, followed by maintenance infusions every 8 weeks. However, the exact dosage and schedule can vary, so it is important for patients to follow their healthcare provider’s specific instructions. Always consult with a healthcare professional for the most accurate and personalized dosage information.
Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, crohn’s disease, ulcerative colitis, plaque psoriasis
Generally well-tolerated with similar safety profile to Remicade.
Interactions not reported
$200 – $300
$1,200

A Synopsis of

Inflectra

Inflectra is a medication that falls under the category of biosimilars, which are drugs that are highly similar to already approved biologic medications. It is used to treat a variety of inflammatory conditions, such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

The active ingredient in Inflectra is infliximab, which works by targeting and blocking a specific protein in the body that is responsible for causing inflammation. By doing so, Inflectra helps to reduce inflammation and alleviate symptoms associated with these conditions.

It is important to note that Inflectra should only be used under the guidance and supervision of a healthcare professional, as it is administered via injection or infusion. Your healthcare provider will determine the appropriate dosage and frequency of administration based on your specific condition and individual needs.

As with any medication, Inflectra may cause side effects in some individuals. Common side effects may include headache, nausea, fever, and injection site reactions. It is important to report any unusual or severe side effects to your healthcare provider promptly.

Overall, Inflectra has been shown to be an effective treatment option for many individuals suffering from inflammatory conditions. If you have been prescribed Inflectra, be sure to follow your healthcare provider’s instructions carefully and communicate any concerns or questions you may have. Your healthcare provider is there to support you and ensure that you receive the best possible care.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN